New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
PBM
2.97
0.11
+3.85%
After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.
Follow PBM
Alert me
| Sep '25 | Mar '25 | Sep '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
8.09 | 11.04 | 0.64 | 0.09 |
+8 more quarters Free account |
Net Debt/EBITDA |
4.78 | — | 1.70 | — | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | — | |
Operating CF/Net income |
— | — | — | 0.00 | |
Capex/Depreciation |
(0.08) | — | (3.56) | (28.50) | |
Interest Coverage |
(537.96) | — | (312.73) | — | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | — | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow per Share |
— | — | — | 0.00 | |
Cash per Share |
30.37 | — | 350.38 | — | |
Shareholders Equity per Share |
50.07 | — | (224.12) | — | |
Interest Debt per Share |
0.00 | — | 0.00 | — | |
Book value per Share |
50.07 | — | (224.12) | — | |
Free Cash Flow |
(2.03) | — | (1.52) | (2.95) | |
Working Capital |
6.69 | 5.97 | (1.27) | (10.98) | |
Capital Expenditures |
0.00 | — | (0.01) | (0.01) | |
Net Current Asset Value |
6.69 | 5.97 | (1.27) | (10.98) | |
| Other line items | |||||
Quick Ratio |
7.82 | 10.61 | 0.59 | 0.07 | |
Operating CF per Share |
— | — | — | 0.00 | |
Capex per Share |
— | — | — | 0.00 | |
Average Receivables |
0.11 | 0.10 | 0.09 | 0.44 | |
Average Assets |
14.61 | 133.12 | 129.37 | 129.47 | |
Average Common Equity |
4.19 | 4.09 | 0.13 | 116.84 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates